EMEA-003597-PIP01-24
Submitted by Anonymous (not verified) on 24 June 2025 - 8:48
EMEA-003597-PIP01-24
EMEA-003596-PIP01-24
Submitted by Anonymous (not verified) on 24 June 2025 - 8:43
EMEA-003596-PIP01-24
EMEA-003594-PIP01-24
Submitted by Anonymous (not verified) on 23 June 2025 - 17:10
EMEA-003594-PIP01-24
EMEA-003593-PIP01-24
Submitted by Anonymous (not verified) on 23 June 2025 - 16:48
EMEA-003593-PIP01-24
EMEA-003593-PIP02-24
Submitted by Anonymous (not verified) on 23 June 2025 - 16:48
EMEA-003593-PIP02-24
EMEA-003192-PIP02-23
Submitted by Anonymous (not verified) on 23 June 2025 - 16:05
EMEA-003192-PIP02-23
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 15, Status: Authorised
Submitted by Anonymous (not verified) on 23 June 2025 - 15:33
Human medicines European public assessment report (EPAR): Lorviqua, lorlatinib, Date of authorisation: 06/05/2019, Revision: 15, Status: Authorised
Article 57 product data
Submitted by Anonymous (not verified) on 23 June 2025 - 15:10
Article 57 product data
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - November 2025, Online, from 19 November 2025, 14:00 (CET) to 21 November 2025, 18:30 (CET)
Submitted by Anonymous (not verified) on 23 June 2025 - 14:27
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - November 2025, Online, from 19 November 2025, 14:00 (CET) to 21 November 2025, 18:30 (CET)
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - October 2025, Online, from 20 October 2025, 09:00 (CEST) to 22 October 2025, 13:30 (CEST)
Submitted by Anonymous (not verified) on 23 June 2025 - 14:26
eXtended EudraVigilance Medicinal Product Dictionary (XEVMPD) training course - October 2025, Online, from 20 October 2025, 09:00 (CEST) to 22 October 2025, 13:30 (CEST)